Castle Biosciences Inc (CSTL)

EBITDA Margin

2.48%

Quarterly · Period ending:

CSTL logo

CSTL EBITDA Margin

Latest reported2.48%
CSTL Quarterly EBITDA Margin (-82.56% → 2.48%)
High-resolution chart · PNG

CSTL ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Castle Biosciences Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
2.4849%
-12.3687%
1.2493%
4.1593%
3.8196%
3.9892%
15.925%
14.0169%
13.2227%
1.1854%
1.036%
-6.0121%
-31.3495%
-62.5497%
-46.21%
-46.7969%
-2.7929%
-83.1782%
-54.7266%
-45.5889%
-35.8204%
-17.7399%
-24.5679%
-24.7355%
-3.9717%
8.1812%
16.9677%
47.5702%
4.7589%
-2.91%
40.2815%
-75.381%
-64.0731%
-82.5588%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.